DK0701612T3 - Immunogent præparat af OspC-antigenvacciner til forebyggelse og behandling af Lyme sygdom og rekombinantmetode til fremsti - Google Patents

Immunogent præparat af OspC-antigenvacciner til forebyggelse og behandling af Lyme sygdom og rekombinantmetode til fremsti

Info

Publication number
DK0701612T3
DK0701612T3 DK94915562T DK94915562T DK0701612T3 DK 0701612 T3 DK0701612 T3 DK 0701612T3 DK 94915562 T DK94915562 T DK 94915562T DK 94915562 T DK94915562 T DK 94915562T DK 0701612 T3 DK0701612 T3 DK 0701612T3
Authority
DK
Denmark
Prior art keywords
preparation
prevention
treatment
lyme disease
ospc
Prior art date
Application number
DK94915562T
Other languages
English (en)
Inventor
Brian Crowe
Friedrich Dorner
Ian Livey
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Application granted granted Critical
Publication of DK0701612T3 publication Critical patent/DK0701612T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK94915562T 1993-04-29 1994-04-29 Immunogent præparat af OspC-antigenvacciner til forebyggelse og behandling af Lyme sygdom og rekombinantmetode til fremsti DK0701612T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5386393A 1993-04-29 1993-04-29
PCT/EP1994/001365 WO1994025596A2 (en) 1993-04-29 1994-04-29 IMMUNOGENIC FORMULATION OF OspC ANTIGEN VACCINES FOR THE PREVENTION AND TREATMENT OF LYME DISEASE AND RECOMBINANT METHODS FOR THE PREPARATION OF SUCH ANTIGENS

Publications (1)

Publication Number Publication Date
DK0701612T3 true DK0701612T3 (da) 1998-09-21

Family

ID=21987063

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94915562T DK0701612T3 (da) 1993-04-29 1994-04-29 Immunogent præparat af OspC-antigenvacciner til forebyggelse og behandling af Lyme sygdom og rekombinantmetode til fremsti

Country Status (16)

Country Link
EP (1) EP0701612B1 (da)
JP (1) JPH08509371A (da)
AT (1) ATE162550T1 (da)
AU (1) AU683260B2 (da)
CA (1) CA2161534A1 (da)
CZ (1) CZ289212B6 (da)
DE (1) DE69408135T2 (da)
DK (1) DK0701612T3 (da)
ES (1) ES2114687T3 (da)
FI (1) FI955150L (da)
HR (1) HRP940279B1 (da)
HU (1) HU217024B (da)
NO (1) NO954318L (da)
PL (1) PL178775B1 (da)
SK (1) SK279968B6 (da)
WO (1) WO1994025596A2 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5915049A (en) * 1992-02-25 1999-06-22 Pfu Limited Binarization system for an image scanner
US7008625B2 (en) 1993-11-01 2006-03-07 Research Foundation Of The State University Of New York Recombinant constructs of Borrelia burgdorferi
US6716574B2 (en) 1996-05-02 2004-04-06 Dako A/S Osp-C derived peptide fragments
DE896583T1 (de) * 1996-05-02 2000-03-09 Statens Seruminstitut Neue osp-c abgeleitete peptidefragmente
US5846946A (en) * 1996-06-14 1998-12-08 Pasteur Merieux Serums Et Vaccins Compositions and methods for administering Borrelia DNA
AT405940B (de) * 1996-06-21 1999-12-27 Immuno Ag Verfahren zur gewinnung und reinigung von rekombinantem, nicht-lipidiertem osp-protein
DE19629543C2 (de) * 1996-07-22 1999-02-11 Immuno Ag Immunassay zum Nachweis von anti-B. burgdorferi Antikörpern und Verfahren zur Serodiagnose bei Lyme Borreliose, diagnostische Mittel und Testkits zur Durchführung der Verfahren
DE19740735A1 (de) 1997-09-16 1999-03-18 Max Planck Gesellschaft Arzneimittel zur Therapie einer manifesten Lyme-Borreliose
PT1100922E (pt) 1998-07-31 2008-05-30 Gundersen Lutheran Medical Fou Utilização do(s) epítopo(s) borrelicida(s) da proteína de superfície externa c (ospc) de borrelia burgdorferi, como vacina
DE60030859T2 (de) 1999-06-18 2007-06-14 The Research Foundation Of State University Of New York Gruppen von borrelia burgdorferi, die lyme krankheit verursachen
AU2001285049A1 (en) 2000-08-18 2002-03-04 Brookhaven Sciences Associates, Llc Altered ospa of borrelia burgdorferi
GB2414667A (en) * 2004-06-03 2005-12-07 Isis Innovation Vaccine compositions of N. meningitidis PorA and FetA antigens
US7794727B2 (en) * 2005-11-29 2010-09-14 Virginia Commonwealth University Polyvalent chimeric OspC vaccinogen and diagnostic antigen
BRPI0719360B1 (pt) * 2006-11-03 2016-09-06 Intervet Int Bv vacina da doença de lyme canina, e, uso de organismos de uma genoespécie de borrelia
CZ301244B6 (cs) * 2007-11-14 2009-12-16 Bioveta, A.S. Univerzální vakcína k lécbe a prevenci Lymeské borreliózy pro humánní a veterinární použití a zpusob její výroby
CZ301548B6 (cs) * 2008-08-20 2010-04-14 Bittner@Libor Univerzální preparát ke zvýšení obranyschopnosti, prevenci, profylaxi a lécbe Lymeské boreliózy pro humánní a veterinární použití, zpusob jeho výroby a použití
WO2025015077A1 (en) * 2023-07-10 2025-01-16 Dynavax Technologies Corporation Lyme disease vaccines comprising an adjuvant and borrelia outer surface protein a and c antigens

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6221363B1 (en) * 1991-07-11 2001-04-24 Baxter Aktiengesellschaft Vaccine for the prevention of lyme disease

Also Published As

Publication number Publication date
FI955150A7 (fi) 1995-12-28
SK134195A3 (en) 1996-05-08
DE69408135D1 (de) 1998-02-26
ES2114687T3 (es) 1998-06-01
HUT72923A (en) 1996-06-28
PL311301A1 (en) 1996-02-05
DE69408135T2 (de) 1998-06-10
CZ283995A3 (en) 1996-03-13
HU9502002D0 (en) 1995-08-28
HRP940279A2 (en) 1997-10-31
FI955150L (fi) 1995-12-28
PL178775B1 (pl) 2000-06-30
NO954318L (no) 1995-12-29
AU6722994A (en) 1994-11-21
CZ289212B6 (cs) 2001-12-12
WO1994025596A2 (en) 1994-11-10
EP0701612B1 (en) 1998-01-21
HU217024B (hu) 1999-11-29
ATE162550T1 (de) 1998-02-15
HRP940279B1 (en) 2000-12-31
FI955150A0 (fi) 1995-10-27
SK279968B6 (sk) 1999-06-11
WO1994025596A3 (en) 1994-12-22
AU683260B2 (en) 1997-11-06
NO954318D0 (no) 1995-10-27
EP0701612A1 (en) 1996-03-20
JPH08509371A (ja) 1996-10-08
CA2161534A1 (en) 1994-11-10

Similar Documents

Publication Publication Date Title
HUT72923A (en) Immunogenic formulation of ospc antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens
NO913518L (no) Vaksiner for ikke typebestembar haemophilus influenzae.
DK0598816T3 (da) Osp A-proteiner fra Borrelia Burgdorferi-undergrupper, hvilke proteiner koder for gener og vacciner
FI953608A7 (fi) Rokoteyhdisteet ja menetelmä immuunireaktion aikaansaamiseksi limakalv ossa järjestelmällisellä rokottamisella
DK1203817T3 (da) Forbindelser og fremgangsmåder til immunterapi og diagnose af tuberkulose
DK96493D0 (da) Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaaden
GB2303855B (en) Helicobacter pylori antigenic protein preparation and immunoassays
NZ331651A (en) BSW17 peptide immunogens for vaccination against and treatment of allergy
AU1955088A (en) Avirulent microbes, incapable of producing functional adenylate cyclase and cyclic AMP
DK0900380T3 (da) Fremgangsmåde til udvælgelse og fremstilling af T-celle-peptid-epitoper og vacciner indeholdende disse udvalgte epitoper
DK1104306T3 (da) Præparater af CpG- og saponinadjuvanser og fremgangsmåder til anvendelse deraf
ATE475668T1 (de) Immunisierung durch impfung von dns transkriptionseinheit
DK157087A (da) Multivalent vaccine, isaer herpesvirusvaccine, dens anvendelse og deri indgaaende virus
ATE446368T1 (de) Antigene aus neisseria meningitidis
DE69112634D1 (de) Immunogene komplexe, insbesondere iscoms.
DK0880360T3 (da) Hidtil ukendte fremgangsmåder til vaccination og vacciner dertil, hvilke vacciner omfatter en nucleinsyre, der koder en første epitop, og et peptid, der indeholder en sekundær epitop
DK1238086T3 (da) Vaccine til forögelse af immunreaktioner på herpes simplex virus
DK218886A (da) Tvaerreaktive og beskyttende epitoper af circumsporozoit-proteiner
CA1272124C (en) Marginal Anaplasma Subunit Antigen for Vaccination and Diagnostic Purposes
SE9604322D0 (sv) Bacterial antigens and vaccine compositions II
WO2000039301A3 (en) Methods for using mycobacterium tuberculosis molecules as immunological adjuvants
WO1999015692A3 (en) Dengue virus antigens and treatment of dengue fever
ATE206138T1 (de) Helicobacter pylori antigen
SE9600646D0 (sv) Vaccin
MX9700215A (es) Proteinas y vacunas de helicobacter.